ARCA biopharma, Inc. company info

CIK 907654
IRS Number 363855489
State of incorporation DE
Business address 11080 CIRCLEPOINT ROAD
SUITE 140
WESTMINSTER
CO
80020
Mail address 11080 CIRCLEPOINT ROAD
SUITE 140
WESTMINSTER
CO
80020

Short summary

ARCA biopharma, Inc. is a Colorado company, with head office located at 11080 Circlepoint Road Westminster, Colorado 80020. In 2018 the company owned a total of 10.39 million USD worth of assets, including 10.32 million USD worth of current assets. 2014 was the year when the company amassed the most assets.

ARCA biopharma, Inc. Income Statement

Name [in Millions USD]200420052006200720082009201020112012201320142015201620172018Trends
Selling, General and Administrative Expense 6.075.053.234.01
Research and development 3.112.321.092.935.637.0612.3514.084.24
Operating Expenses 9.187.364.326.949.6911.4616.6118.718.12
Operating Income (Loss) -9.18-7.36-4.32-6.94-9.69-11.46-16.61-18.71-8.12
Interest expense 0.000.000.000.010.01
Income Tax Expense (Benefit) 000-0.06-0.03
Net income -0.51-1.46-5.24-13.99-19.43-9.14-8.42-5.36-4.32-6.94-9.69-11.45-16.44-18.49-7.93

ARCA biopharma, Inc. Balance Sheet

Name [in Millions USD]200420052006200720082009201020112012201320142015201620172018Trends
Cash and cash equivalents 9.927.463.1820.3719.3844.0914.389.109.649.97
Deferred income taxes 00
Property, Plant and Equipment, Gross 0.530.520.430.430.450.450.430.39
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment 0.490.500.400.390.370.400.400.38
Other Assets, Noncurrent 0.260.180.100.830.750.820.590.020.02
Total assets 8.583.8220.7820.5445.1232.6417.3010.0710.39
Current assets 7.833.5920.6619.6844.3326.7416.6610.0110.32
Accounts payable 0.520.230.390.730.710.761.070.410.25
Total current liabilities 1.000.530.751.221.361.702.521.061.20
Deferred income taxes
Total liabilities 1.040.530.751.221.361.742.551.070.79
Common Stock, Value, Issued 0.010.010.010.020.060.010.010.010.00
Retained Earnings (Accumulated Deficit) -60.22-66.23-70.26-79.73-90.09-103.61-122.37-135.85-142.03
Accumulated Other Comprehensive Income (Loss), Net of Tax 0.01-0.01-0.00

ARCA biopharma, Inc. Cash Flow

Name [in Millions USD]200420052006200720082009201020112012201320142015201620172018Trends
Net income -0.51-1.46-5.24-13.99-19.43-9.14-8.42-5.36-4.32-6.94-9.69-11.45-16.44-18.49-7.93
Depreciation and amortization 0.340.600.040.030.010.020.020.030.02
Depreciation and amortization 0.600.040.03
Accounts payable -0.15-0.13-0.200.530.20-0.430.84-0.58-0.39
Net Cash Provided by (Used in) Operating Activities -8.32-6.96-4.08-5.29-17.47-8.24
Payments to Acquire Property, Plant, and Equipment 0.000.020.030.020.010.010.000.00
Net Cash Provided by (Used in) Investing Activities 0.272.01-0.0312.933.05
Net Cash Provided by (Used in) Investing Activities, Continuing Operations -0.03-0.02-0.01-16.4112.93
Stock Issued During Period, Value, Share-based Compensation, Net of Forfeitures 0.040.050.550.850.460.31
Stock Issued During Period, Value, Share-based Compensation, Net of Forfeitures 0.040.050.550.850.460.31
Proceeds from Issuance of Common Stock 7.664.731.531.749.04376.553.53
Net Cash Provided by (Used in) Financing Activities 7.323.871.0619.165.853.10
Cash and Cash Equivalents, Period Increase (Decrease) -0.74-1.08-3.0213.84-1.401.30-2.09